Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Double-Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

NCT02612922 is registered in ClinicalTrials.gov with Romark Laboratories L.C. as lead sponsor.

NCT NCT02612922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Double-Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Lead sponsor
Romark Laboratories L.C.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
September 4, 2016
Enrollment
325 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

influenza